Recombinant erythropoietin rapidly treats anemia in ischemic acute renal failure
- 1 January 2001
- journal article
- Published by Elsevier in Kidney International
- Vol. 59 (1) , 246-251
- https://doi.org/10.1046/j.1523-1755.2001.00485.x
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- A Potential Role for Erythropoietin in Focal Permanent Cerebral Ischemia in MiceJournal of Cerebral Blood Flow & Metabolism, 1999
- Human, rat, and mouse kidney cells express functional erythropoietin receptorsKidney International, 1999
- In vivo evidence that erythropoietin protects neurons from ischemic damageProceedings of the National Academy of Sciences, 1998
- Mechanisms contributing to muscle-wasting in acute uremiaJournal of the American Society of Nephrology, 1998
- Treatment of acute renal failureKidney International, 1998
- Erythropoietin Ameliorates Anemia of Cisplatin Induced Acute Renal FailureAsaio Journal, 1998
- Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal deathNeuroscience, 1996
- Erythropoietin production in rats with post-ischemic acute renal failureKidney International, 1996
- Effect of haemoglobin and endogenous erythropoietin on hypothalamic‐pituitary thyroidal and gonadal secretion: an analysis of anaemic (high EPO) and polycythaemic (low EPO) patientsClinical Endocrinology, 1995
- Pharmacodynamics and therapeutic usage of recombinant human erythropoietin (SNB-5001) in animal models.Folia Pharmacologica Japonica, 1992